Feasibility of Using NeuraSignal Transcranial Doppler Robot
ConditionCerebral Autoregulation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Alabama at Birmingham
About this trial
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-89
Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
Disqualifiers
Patients under 18 years (or bodyweight <50kg if age unknown),
prisoners
pregnant women,
non-English speaking,
Trial population
Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
NeuraSignal transcranial doppler robot
Devicemeasure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: Study Group1 intervention
Trial outcomes
Primary outcomes
1
Primary outcome
Cerebral autoregulatory curve generation using the NeuraSignal transcranial doppler robot correlated with arterial blood pressure measurements in neuro ICU patients admitted for blood pressure management after spinal surgery
Time frame
one yearSecondary outcomes
1
Secondary outcome
left or right shifting of the autoregulatory curve as a result of vasopressor use
Time frame
one yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: